- Home
- TEVA vs ES Comparison
TEVA vs ES Comparison
Compare TEVA & ES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- ES
- Stock Information
- Founded
- TEVA 1901
- ES 1927
- Country
- TEVA Israel
- ES United States
- Employees
- TEVA N/A
- ES N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- ES Electric Utilities: Central
- Sector
- TEVA Health Care
- ES Utilities
- Exchange
- TEVA Nasdaq
- ES Nasdaq
- Market Cap
- TEVA 18.4B
- ES 21.1B
- IPO Year
- TEVA N/A
- ES N/A
- Fundamental
- Price
- TEVA $15.30
- ES $62.08
- Analyst Decision
- TEVA Strong Buy
- ES Buy
- Analyst Count
- TEVA 6
- ES 11
- Target Price
- TEVA $24.00
- ES $67.40
- AVG Volume (30 Days)
- TEVA 11.2M
- ES 2.2M
- Earning Date
- TEVA 05-07-2025
- ES 04-30-2025
- Dividend Yield
- TEVA N/A
- ES 4.85%
- EPS Growth
- TEVA N/A
- ES N/A
- EPS
- TEVA N/A
- ES 2.27
- Revenue
- TEVA $16,544,000,000.00
- ES $11,900,809,000.00
- Revenue This Year
- TEVA $5.31
- ES $12.73
- Revenue Next Year
- TEVA $1.18
- ES $2.44
- P/E Ratio
- TEVA N/A
- ES $27.35
- Revenue Growth
- TEVA 4.41
- ES N/A
- 52 Week Low
- TEVA $12.51
- ES $54.75
- 52 Week High
- TEVA $22.80
- ES $69.01
- Technical
- Relative Strength Index (RSI)
- TEVA 37.96
- ES 56.13
- Support Level
- TEVA $14.70
- ES $58.75
- Resistance Level
- TEVA $15.53
- ES $62.35
- Average True Range (ATR)
- TEVA 0.50
- ES 1.20
- MACD
- TEVA -0.01
- ES 0.07
- Stochastic Oscillator
- TEVA 27.03
- ES 91.48
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. The company expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. The company exited most of its unregulated businesses in 2006.